Objective: Hysteroscopic procedures are minimally invasive procedures that enable to assess the uterine cavity (diagnostic hysteroscopy) and to treat intrauterine lesions (operative hysteroscopy). In recent years have witnessed a steady increase in the number of procedures performed via minimally invasive surgery (MIS) including hysteroscopies. Most outpatient hysteroscopies are painless, without complications, and not only allow to diagnose but also treat several intrauterine pathologies. Vaginoscopy hysteroscopy without using speculum, tenaculum and other potentially painful instrumentation should become the default method for outpatient hysteroscopy. This ‘no-touch’ technique is faster in contrary to standard hysteroscopy and is associated with less pain. Mechanism: A wide range of feasible procedures, constantly improved endoscopic equipment and tools, improving the technical conditions of the procedure, as well as short hospitalization time and a quick recovery period, are just some of the benefits of hysteroscopic surgeries. Findings in Brief: Performing hysteroscopy in an outpatient setting without general anesthesia addictionally reduces treatment cost and avoid of possible complications of general anesthesia. Conclusions: Performing hysteroscopy in an outpatient setting without general anesthesia (with the patient’s consciousness preserved during the surgery) reduces treatment cost and shortens the duration of hospitalization and convalescence, thus increasing patient satisfaction with care.
(1) Background: there is a steady increase in the number of procedures performed via minimally invasive surgery, which have many benefits, but post-operative nausea and vomiting (PONV) and significant pain are still a common problem (2) Methods: 300 infertile women (18–40 years old) undergoing minimal invasive surgery. Interventions: laparoscopy and hysteroscopy performing, evaluation of postoperative symptoms, serotonin concentrations assessment, identify genetic polymorphisms. (3) Results: serotonin concentrations were significantly lower among women who required opioids (p = 0.006). The presence of the GG genotype in the rs6318 polymorphism of the 5HTR2C gene had a protective effect on PONV (OR = 0.503; C.I. = [0.300–0.841]; p = 0.008), when the GG variant of the rs11214763 polymorphism of the 5HTR3B gene, when the risk of PONV was 1.65-fold higher (OR = 1.652; C.I. = [1.003–2.723]; p = 0.048). Pain intensity was significantly higher among women with GG genotype of the rs6296 polymorphism of the 5HTR1B gene (OR = 1.660; C.I. = [1.052–2.622]; p = 0.029).; (4) Conclusions: the evaluation of serotonin concentration predicts requirement for opioid pain relief medication. The polymorphisms of the serotonin receptors affect the intensity of postoperative complaints.
21 September 2022 in Clinical and Experimental Obstetrics & Gynecology
Objectives: A review to assess the safety, efficacy, COVID-19 vaccination acceptance and awareness in pregnant women. Machanism: Pregnant women diagnosed with COVID-19 are characterized by more frequent hospitalization in intensive care units and are at three times higher risk of preterm; their newborns more often need invasive ventilation. Vaccination is the most effective preventive measures against SARS-CoV-2, but there are still questions about safety and immune response. Pregnant women were not included in study groups during phase III clinical trials. Findings in Brief: Vaccination during pregnancy is not associated with an increased risk of obstetric or neonatal complications; scientific communities recommend vaccination for pregnant women, those planning for pregnancy and those who are breastfeeding. Unfortunately, knowledge regarding COVID-19 vaccination and willingness to take vaccine during pregnancy is low. Conclusions: General practitioners and obstetricians have a large role in increasing public awareness of COVID-19 vaccination. No evidence of teratogenicity of the vaccine has been found.